Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026)

Palvella Therapeutics (PVLA) has 13 years of Non-Current Assets data on file, last reported at $528000.0 in Q1 2026.

• Quarterly Non-Current Assets changed N/A year-over-year to $528000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 283.28% YoY) and the FY2025 annual result came in at $572000.0, changed N/A from the prior year.
• Non-Current Assets fell to $528000.0 in Q1 2026 per PVLA's latest filing, from $572000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $25.4 million in Q1 2022 and bottomed at $287000.0 in Q3 2023.
• The 4-year median for Non-Current Assets is $21.1 million (2023), against an average of $15.1 million.
• The widest annual swing landed in 2022, when Non-Current Assets dropped 7.81%; it then plunged 98.61% in 2023.
• Tracing PVLA's Non-Current Assets over 4 years: stood at $22.1 million in 2022, then tumbled by 98.7% to $287000.0 in 2023, then soared by 99.3% to $572000.0 in 2025, then fell by 7.69% to $528000.0 in 2026.
• Per Business Quant, the three latest PVLA Non-Current Assets figures stand at $528000.0 (Q1 2026), $572000.0 (Q4 2025), and $287000.0 (Q3 2023).

Peer Comparison